Gastric cancer: an update. Review uri icon

Overview

abstract

  • Gastric cancer is an aggressive malignancy, which, if metastatic or unresectable, is incurable. However, with metastatic or unresectable disease, patients receive a palliative benefit from chemotherapy. Although the understanding of the biology of this disease is increasing, the development of biologically targeted therapies for gastric cancer has been limited. Cytotoxic therapy remains the standard approach, and although there is agreement on the active agents and active combination chemotherapy regimens, consensus on the standard or reference regimen is lacking. This article reviews the pathophysiology of this disease, placing it in the context of its epidemiology, and the current advances in the treatment of this disease.

publication date

  • May 1, 2006

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Stomach Neoplasms

Identity

Scopus Document Identifier

  • 33646259706

Digital Object Identifier (DOI)

  • 10.1007/s11912-006-0018-4

PubMed ID

  • 16618382

Additional Document Info

volume

  • 8

issue

  • 3